-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.P1.56 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I

Symposia: Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Lynn Malec, MD, MSc1,2, Hanna Salehi, MSc3*, Nathan Ball, BSc3*, Sophie Lai, BSc4* and Marion Afonso5*

1Versiti Blood Research Institute, Wauwatosa, WI
2Division of Hematology & Oncology, Departments of Medicine and Pediatrics, Medical College of Wisconsin, Milwaukee, WI
3Adelphi Real World, Bollington, United Kingdom
4Adelphi Real World, Macclesfield, United Kingdom
5Sanofi, Gentilly, France

Seug Yun Yoon1*, Sun Young Jeong1*, Seong Soon Kwon2*, Mina Kim3*, Min-Young Lee4*, Kyoung Ha Kim5*, Namsu Lee4* and Jong-Ho Won, MD4

1Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of (South)
2Division of Cardiology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, KOR
3Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, Korea, Republic of (South)
4Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, KOR
5Division of Hematology & Medical Oncology, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, KOR

Paul Dolin1*, Thanai Pongdee2, Priya Jain1, Jennifer Rowell3*, Chris Edmonds4*, James M. Eudicone5*, Amanda M. Moore6*, Thomas Peer7*, Kinwei Arnold Chan6* and Stephanie Yanjing Chen8*

1BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
2Division of Allergic Diseases, Mayo Clinic, Rochester, MN
3Market Access and Pricing, AstraZeneca, Cambridge, United Kingdom
4Market Access and Pricing, AstraZeneca, Gaithersburg, MD
5Real World Science and Analytics, AstraZeneca, Wilmington, DE
6TriNetX, Cambridge, MA
7TriNetX, Farmington, NY
8BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD

Jennifer MacWhirter - DiRaimo1*, Laura Bou-Maroun, MD2*, Debbie Jiang, MD3,4*, Caroline Kruse1*, Michele P. Lambert, MD5,6, Cindy Neunert, MD7, Allison Remiker, MD8*, Melissa J Rose, DO9,10, Kevin Won1,11* and Rachael F. Grace, MD, MMSc4,12

1Platelet Disorder Support Association, Cleveland, OH
2University of Michigan, Michigan
3Massachusetts General Hospital, Boston, MA
4Harvard Medical School, Boston, MA
5Children's Hospital of Philadelphia, Philadelphia, PA
6Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
7Department of Pediatrics, Columbia University Irving Medical Center, New York, NY
8Medical College of Wisconsin, Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Milwaukee, WI
9Division of Pediatric Hematology & Oncology, Nationwide Children's Hospital, Department of Pediatrics, The Ohio State University, Columbus, OH
10Ohio State University, Columbus
11Queens Medical School, Kingston, ON, Canada
12Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

Giancarlo Castaman, MD1*, Cléa Percier, PharmD2*, Naveen Shridhar, MBBS, PhD3*, Neil Reynolds4*, Olivera Rajkovic-Hooley4*, Thom Dewar4* and Víctor Jiménez-Yuste, MD, PhD5*

1Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy
2Novo Nordisk Health Care AG, Zürich, Switzerland
3Novo Nordisk Service Centre India Private Limited, Bangalore, India
4Adelphi Real World, Bollington, United Kingdom
5Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain

Jessica M. Stempel, MD1,2, Rong Wang, PhD2,3*, Alfred I Lee, MD, PhD1, Xiaomei Ma, PhD2,3* and Nikolai A. Podoltsev, MD, PhD1

1Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
2Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT
3Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT

Anya Parekh, MD, MPH1, Cody Angerman, PharmD2*, Marvin Sanchez, RN3*, NguyenHuong Doan, MD4*, Anjlee Mahajan, MD5 and Adam Giermasz, MD, PhD6*

1Hematology Oncology, University of California, Davis Health, Sacramento, CA
2Specialty Pharmacy, University of California, Davis Health, Sacramento, CA
3UC Davis Health: HEMOPHILIA TREATMENT CENTER, Sacramento
4Internal Medicine, University of California, Davis Health, Sacramento
5University of California, Davis, Sacramento, CA
6Hemophilia Treatment Center, University of California Davis, Sacramento, CA

Esther Natalie Oliva, MD1, Antonio M Risitano, MD, PhD2, Eros Di Bona, MD3*, Alessandro Maria Vannucchi4, Ilaria Maria Delfino1*, Antonio De Vivo, MD5*, Valentina Giai, MD, PhD6*, Rosario Notaro, MD4*, Giuseppe Ianni'7*, Eloise Beggiato, MD8*, Simona Sica, MD, PhD9*, Gaetano La Barba, MD10*, Sneha Balakrishnan11*, Tanuja Thavarajah11*, Simona Raso, MD12*, Raffaele Fontana, MD13*, Wilma Barcellini, MD14*, Bruno Fattizzo, MD14, Roochi Trikha11*, Luana Marano, MD2*, Jens Panse, MD15 and Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP11,16,17

1Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
2Hematology and BMT Unit, AORN San Giuseppe Moscati, Avellino, Italy
3UOC Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa (VI), Vicenza, Italy
4SOD Ematologia, Azienda Ospedaliera Universitaria Careggi di Firenze, Firenze, Italy
5Institute Of Hematology, Bologna, Italy
6Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy
7Dielnet SRL, CRO, Reggio Calabria, Italy
8Hematology, AOU Città della Salute e della Scienza di Torino-Presidio Ospedaliero Molinette, Turin, Italy
9Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Sacro Cuore, Rome, Italy
10Department of Medicine and Aging Sciences, University of Chieti-Pescara, Italy, Pescara, Italy
11King's College Hospital NHS Foundation Trust, London, United Kingdom
12Department of Hematology and Rare Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
13Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
14S.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
15Center of Integrated Oncology (CIO), Aachen, Bonne, Cologne, Düsseldorf (ABCD), Germany
16National Institute for Health Research and Wellcome King's Clinical Research Facility, London, United Kingdom
17King's College Hospital, London, United Kingdom

Ashwin Kishtagari, MBBS1, Zachary Copeland, MPH2*, Tracy Stewart3*, Julie Ryder3*, Carol Ragon4*, KiOsha Carlyle4*, Kerri Harrison5*, Clayton Allen, MD6*, Ryan Yates, MD7*, Andrew Benefield6*, Nina Logan, MD8, Brion Randolph, MD9, Salil Goorha, MD10, Lammers Philip, MD3*, Alexander G. Bick, MD, PhD11* and Michael R. Savona, MD12

1Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Franklin, TN
2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
3Baptist Medical Group, Baptist Memorial Healthcare, Memphis, TN
4Baptist Clinical Research Institute, Baptist Memorial Healthcare, Oxford, MS
5Baptist Clinical Research Institute, Baptist Memorial Healthcare, Oxford, TN
6Baptist Medical Group, Baptist Memorial Healthcare, Oxford, MS
7Baptist Memorial Hospital-North Mississippi, Oxford, MS
8The Leukemia & Lymphoma Society, Atlanta, GA
9Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, TN
10Baptist Memorial Hospital, Memphis, TN
11Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN
12Vanderbilt University Medical Center, Nashville, TN

Jacqueline N Poston, MD1, Binh Le, PhD2*, Brandi Dupervil, DHSC, MPH2* and J Michael Soucie, PhD3,4*

1Larner College of Medicine at The University of Vermont, Burlington, VT
2Division of Blood Disorders and Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA
3Peers & Partners, Inc, Atlanta, GA
4Division of Blood Disorders and Public Health Genomics, Centers For Disease Control and Prevention, Atlanta, GA

Louis A Jackson III, PharmD1*, Jacqueline Pesa, MSEd, PhD, MPH2*, Zia Choudhry, MD, PhD, MBA2*, Shannon Ferrante2*, Alicia K Campbell, PharmD2* and Caroline Piatek, MD3

1Janssen Scientific Affairs, LLC, Horsham, PA
2Janssen Scientific Affairs, LLC, Titusville, NJ
3Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, USC Norris Comprehensive Cancer Center, Los Angeles, CA

Arvind Suresh, MD1, Marina Heskel, MD2 and Patricia A. Cornett, MD2

1Department of Medicine, University of California, San Francisco, San Francisco, CA
2Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA

Fatima Zafar, MBBS1*, Syed Muhammad Ali Najafi, MBBS1*, Muhammad Imtanan Fazal, MBBS1*, Fnu Shubhangi, MBBS2*, Vaibhavi P Mukhtiar, MBBS3, Umer Talal, MBBS1*, Malik Ahsan Safdar, MBBS1*, Muhammad Romail Manan, MBBS1*, Iqra Nawaz, MBBS4* and Ammad Naeem, MD5*

1Services Hospital, Lahore, Pakistan
2Nalanda medical college and hospital, Patna, India
3Saint Vincent Hospital, WORCESTER, MA
4Bhawal Victoria Hospital, Bhawalpur, Pakistan
5Charleston Area Medical Center, Charleston, WV

David Dingli, MD, PhD1, Connie Zhang, MPH2*, Samantha McStocker, BSc2*, Amanda Healey, MPH2*, Nicholas Kuypers, PhD3*, Mohin Chanpura, MS4*, Hiba Anwar, MPH2*, Jincy Paulose, MD5*, Soyon Lee, PharmD4*, Puja Seth6* and Glorian Yen, PhD, MPH4*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Folia Health, Boston, MA
3Novartis, East Hanover, NJ
4Novartis Pharmaceuticals Corporation, East Hanover, NJ
5Executive Medical Director and Medical Team Lead for NMH at Novartis, Novartis Pharmaceuticals Corporation, East Hanover, NJ
6Long Grove, IL, Chicago

Jana Christian, MD1, Abimbola Aina-Mumuney, MD2*, Kathryn E. Dane, PharmD3, John Lindsley, PharmD3*, Kyle Rosen4*, Rakhi P. Naik, MD1, Jennifer C. Yui, MD, MSc1, Shruti Chaturvedi, MBBS5, Gloria F. Gerber, MD1 and Michael Streiff, MD1

1Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD
2Division of Maternal Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD
3Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD
4Johns Hopkins University School of Medicine, Baltimore, MD
5Division of Hematology, Department of Medicine, Johns Hopkins University, BALTIMORE, MD

Phillip Scheinberg, MD1, Tim H. H. Brummendorf, MD2, Regis Peffault De Latour3*, Carlo Dufour, MD4, Raj Gokani5*, Morag Griffin, MBChB, MRCP6*, Juliana Hey-Hadavi7*, Yoshinobu Kanda8*, Eric Mitchell9*, Barbara Możejko-Pastewka10*, Andres Quintero7*, Patryk Skowron11*, Meltem Kurt Yüksel, MD12* and Alicia Rovó13*

1Hospital A Beneficência Portuguesa, Sao Paulo, SP, Brazil
2RWTH Aachen University, Aachen, Germany
3Hôpital Saint-Louis,, Paris, France
4IRCCS Istituto Giannina Gaslini, Genova, Italy
5Pfizer, Walton Oaks, United Kingdom
6St James’s University Hospital, Leeds, United Kingdom
7Pfizer, New York, NY
8Jichi Medical University, Tochigi, Japan
9Veeva Systems, Pleasanton, CA
10Pfizer, Warsaw, Poland
11Pfizer, Kirkland, QC, Canada
12Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkey
13Bern University Hospital, Bern, Switzerland

Anna Barata1,2*, Richard Newcomb, MD1*, Patrick Connor Johnson, MD2,3, Ella Caruso1*, Porsha Lark1*, Emelia J. Farnam1*, Thomas W. LeBlanc, MD, MA, MS4, Stephanie J. Lee5* and Areej El-Jawahri, MD1

1Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Cancer Center, Massachusetts General Hospital, Boston, MA
4Duke Cancer Institute, Hillsborough, NC
5Fred Hutchinson Cancer Center, Seattle, WA

Chatree Chai-Adisaksopha, M.D., Ph.D.1*, Warawut Chaiwong, Ph.D.2*, Piangrawee Niprapan1*, Adisak Tantiworawit, M.D.1 and Chaiwat Bumroonkit, M.D.2*

1Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
2Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Chiang Mai University, Chiang Ma, Chiang Mai, Thailand

Anand Shah, MBBS1, Rajvi Gor, MBBS2, Abiram Sivanandam, DO3*, Ritik Goyal, MBBS3* and Ankit Shah, MD4*

1Internal Medicine, Rutgers New Jersey Medical School, Harrison, NJ
2Jacobi Medical Center/ Albert Einstein College of Medicine, Bronx, NY
3Rutgers New Jersey Medical School, Newark, NJ
4Rutgers CINJ AT UH, Newark, NJ

*signifies non-member of ASH